We are live on ! Find out more
Tudor Investment Corp

Tudor Investment Corp Portfolio holdings

AUM $53.9B
1-Year Est. Return 29.12%
This Fund
S&P 500
This Quarter Est. Return
+10.98%
1 Year Est. Return
+29.12%
3 Year Est. Return
+77.1%
5 Year Est. Return
+83.79%
10 Year Est. Return
+526.01%
AUM
$2.3B
AUM Growth
+$282M
Cap. Flow
+$200M
Cap. Flow %
8.71%
Top 10 Hldgs %
18.62%
Holding
1,676
New
537
Increased
361
Reduced
311
Closed
438

Sector Composition

Rank Sector Weight
1 Technology 18.17%
2 Industrials 16.67%
3 Consumer Discretionary 10.76%
4 Financials 10.06%
5 Healthcare 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNSL
1201
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$71K ﹤0.01%
+12,545
New +$87K
VHC icon
1202
VirnetX Holding Corp
VHC
$67.6M
$70K ﹤0.01%
667
-816
-55% -$87.3K
VBIV
1203
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$69K ﹤0.01%
+808
New +$94.2K
WPG
1204
DELISTED
Washington Prime Group Inc.
WPG
$69K ﹤0.01%
11,766
ACIC icon
1205
American Coastal Insurance
ACIC
$464M
$68K ﹤0.01%
+11,178
New +$85.8K
KIN
1206
DELISTED
Kindred Biosciences, Inc.
KIN
$68K ﹤0.01%
15,748
-12,536
-44% -$52.4K
WT icon
1207
WisdomTree
WT
$3.4B
$64K ﹤0.01%
+19,889
New +$71.7K
ARLO icon
1208
Arlo Technologies
ARLO
$1.52B
$63K ﹤0.01%
+12,061
New +$58K
PDLI
1209
DELISTED
PDL BioPharma, Inc.
PDLI
$62K ﹤0.01%
19,830
-33,471
-63% -$107K
GSAH.WS
1210
CALL
DELISTED
GS Acquisition Holdings Corp II Redeemable Warrants, each whole warrant exercisable for one share of
GSAH.WS
$54K ﹤0.01%
+24,999
New +$53.9K
ACRS icon
1211
Aclaris Therapeutics
ACRS
$873M
$53K ﹤0.01%
20,750
-37,976
-65% -$85K
FARM
1212
DELISTED
Farmer Brothers
FARM
$52K ﹤0.01%
11,875
-12,859
-52% -$76.3K
CVEO icon
1213
Civeo
CVEO
$347M
$51K ﹤0.01%
6,347
CBIO
1214
Crescent Biopharma
CBIO
$621M
$51K ﹤0.01%
165
-272
-62% -$104K
FCEL icon
1215
FuelCell Energy
FCEL
$1.64B
$46K ﹤0.01%
+723
New +$57.6K
CDR
1216
DELISTED
Cedar Realty Trust, Inc
CDR
$46K ﹤0.01%
8,624
CYH icon
1217
Community Health Systems
CYH
$412M
$45K ﹤0.01%
+10,725
New +$47.3K
PR
1218
Permian Resources
PR
$17.7B
$44K ﹤0.01%
73,216
+8,447
+13% +$6.49K
YELL
1219
DELISTED
Yellow Corporation Common Stock
YELL
$44K ﹤0.01%
+11,153
New +$40.8K
SUP
1220
DELISTED
Superior Industries International
SUP
$42K ﹤0.01%
33,208
SREV
1221
DELISTED
ServiceSource International, Inc.
SREV
$41K ﹤0.01%
27,995
SLDB icon
1222
Solid Biosciences
SLDB
$976M
$40K ﹤0.01%
1,301
-197
-13% -$7.54K
NGD
1223
DELISTED
New Gold Inc
NGD
$37K ﹤0.01%
21,958
-11,879
-35% -$19.1K
GSM icon
1224
FerroAtlántica
GSM
$826M
$34K ﹤0.01%
50,268
TH icon
1225
Target Hospitality
TH
$1.63B
$32K ﹤0.01%
25,842

Similar funds

Tudor Investment Corp's Q3 2020 Portfolio in Review

As of Q3 2020, Tudor Investment Corp held 1,676 positions worth $2.3B, up 14% from $2.02B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tudor Investment Corp deployed $200M of net new capital in Q3 2020, opening 537 new positions and adding to 361 existing holdings. Its largest new stake was National General Holdings Corp: 943,666 shares worth $31.8M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was People Inc, an estimated $68.3M trimmed.

  • Tudor Investment Corp's largest Q3 2020 buy was National General Holdings Corp: 943,666 shares worth $31.8M.
  • Tudor Investment Corp added most to Advanced Disposal Services Inc in Q3 2020, an estimated $74.2M increase.
  • Tudor Investment Corp's biggest Q3 2020 reduction was People Inc, cutting an estimated $68.3M.
  • Tudor Investment Corp fully exited TD Ameritrade Holding Corp in Q3 2020, selling an estimated $95.6M.
  • Tudor Investment Corp's ten largest holdings make up 19% of its $2.3B portfolio in Q3 2020.
  • Tudor Investment Corp opened 537 new positions and closed 438 in Q3 2020.
  • Tudor Investment Corp's portfolio value rose 14% quarter-over-quarter to $2.3B.

Based on Tudor Investment Corp's 13F filing for Q3 2020, filed 16 Nov 2020.